Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileNancy U. Lin, M.D.

TitleAssociate Professor of Medicine
InstitutionDana-Farber Cancer Institute
DepartmentMedicine
AddressDana Farber Cancer Institute
Adult Oncology
44 Binney St
Boston MA 02115
Phone617/632-2335
Fax617/632-1930
vCardDownload vCard (login for email)

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Ladas I, Fitarelli-Kiehl M, Song C, Adalsteinsson VA, Parsons HA, Lin NU, Wagle N, Makrigiorgos GM. Multiplexed Elimination of Wild-Type DNA and High-Resolution Melting Prior to Targeted Resequencing of Liquid Biopsies. Clin Chem. 2017 Jul 05. PMID: 28679646.
    View in: PubMed
  2. Barroso-Sousa R, Lin NU. Reply to Garcia J. et al. Breast. 2017 Aug; 34:132. PMID: 28502743.
    View in: PubMed
  3. Nayak L, DeAngelis LM, Brandes AA, Peereboom DM, Galanis E, Lin NU, Soffietti R, Macdonald DR, Chamberlain M, Perry J, Jaeckle K, Mehta M, Stupp R, Muzikansky A, Pentsova E, Cloughesy T, Iwamoto FM, Tonn JC, Vogelbaum MA, Wen PY, van den Bent MJ, Reardon DA. The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria. Neuro Oncol. 2017 May 01; 19(5):625-635. PMID: 28453751.
    View in: PubMed
  4. Martin AM, Cagney DN, Catalano PJ, Warren LE, Bellon JR, Punglia RS, Claus EB, Lee EQ, Wen PY, Haas-Kogan DA, Alexander BM, Lin NU, Aizer AA. Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based Study. JAMA Oncol. 2017 Mar 16. PMID: 28301662.
    View in: PubMed
  5. Seymour L, Bogaerts J, Perrone A, Ford R, Schwartz LH, Mandrekar S, Lin NU, Litière S, Dancey J, Chen A, Hodi FS, Therasse P, Hoekstra OS, Shankar LK, Wolchok JD, Ballinger M, Caramella C, de Vries EG. iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol. 2017 Mar; 18(3):e143-e152. PMID: 28271869.
    View in: PubMed
  6. Di Meglio A, Lin NU, Freedman RA, Barry WT, Winer EP, Vaz-Luis I. Patterns of Utilization of Imaging Studies and Serum Tumor Markers Among Patients With De Novo Metastatic Breast Cancer. J Natl Compr Canc Netw. 2017 Mar; 15(3):316-324. PMID: 28275032.
    View in: PubMed
  7. Lin N, Li XY, Zhang HM, Yang Z, Su Q. microRNA-199a-5p mediates high glucose-induced reactive oxygen species production and apoptosis in INS-1 pancreatic ß-cells by targeting SIRT1. Eur Rev Med Pharmacol Sci. 2017 Mar; 21(5):1091-1098. PMID: 28338182.
    View in: PubMed
  8. Agarwal A, Freedman RA, Goicuria F, Rhinehart C, Murphy K, Kelly E, Mullaney E, St Amand M, Nguyen P, Lin NU. Prior Authorization for Medications in a Breast Oncology Practice: Navigation of a Complex Process. J Oncol Pract. 2017 Apr; 13(4):e273-e282. PMID: 28245148.
    View in: PubMed
  9. Vaz-Luis I, Lin NU, Keating NL, Barry WT, Winer EP, Freedman RA. Factors Associated with Early Mortality Among Patients with De Novo Metastatic Breast Cancer: A Population-Based Study. Oncologist. 2017 Apr; 22(4):386-393. PMID: 28242790.
    View in: PubMed
  10. Lin N, Huang J, Violante S, Orsini JJ, Caggana M, Hughes EE, Stevens C, DiAntonio L, Chieh Liao H, Hong X, Ghomashchi F, Babu Kumar A, Zhou H, Kornreich R, Wasserstein M, Gelb MH, Yu C. Liquid Chromatography-Tandem Mass Spectrometry Assay of Leukocyte Acid a-Glucosidase for Post-Newborn Screening Evaluation of Pompe Disease. Clin Chem. 2017 Apr; 63(4):842-851. PMID: 28196920.
    View in: PubMed
  11. Zhao Y, Song L, Ding J, Lin N, Wang Q, Du X, Sun R, Han Z. Left Anterior Temporal Lobe and Bilateral Anterior Cingulate Cortex Are Semantic Hub Regions: Evidence from Behavior-Nodal Degree Mapping in Brain-Damaged Patients. J Neurosci. 2017 Jan 04; 37(1):141-151. PMID: 28053037.
    View in: PubMed
  12. Lin NU, Gaspar LE, Soffietti R. Breast Cancer in the Central Nervous System: Multidisciplinary Considerations and Management. Am Soc Clin Oncol Educ Book. 2017; 37:45-56. PMID: 28561683.
    View in: PubMed
  13. Losk K, Vaz-Luis I, Camuso K, Batista R, Lloyd M, Tukenmez M, Golshan M, Lin NU, Bunnell CA. Factors Associated With Delays in Chemotherapy Initiation Among Patients With Breast Cancer at a Comprehensive Cancer Center. J Natl Compr Canc Netw. 2016 Dec; 14(12):1519-1526. PMID: 27956536.
    View in: PubMed
  14. Visvanathan K, Fackler MS, Zhang Z, Lopez-Bujanda ZA, Jeter SC, Sokoll LJ, Garrett-Mayer E, Cope LM, Umbricht CB, Euhus DM, Forero A, Storniolo AM, Nanda R, Lin NU, Carey LA, Ingle JN, Sukumar S, Wolff AC. Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study. J Clin Oncol. 2017 Mar; 35(7):751-758. PMID: 27870562.
    View in: PubMed
  15. Barroso-Sousa R, Paes FR, Vaz-Luis I, Batista RB, Costa RB, Losk K, Camuso K, Metzger-Filho O, Hughes ME, Bunnell CA, Golshan M, Winer EP, Lin NU. Variation in the use of granulocyte-colony stimulating factor for dose dense paclitaxel: A single institution retrospective study. Breast. 2016 Dec; 30:136-140. PMID: 27721193.
    View in: PubMed
  16. Ren H, Zhang G, Lin N, Deng L, Luo Y, Huang F. Strong Fermi level pinning induces a high rectification ratio and negative differential resistance in hydrogen bonding bridged single cytidine pair junctions. Phys Chem Chem Phys. 2016 Sep 29; 18(38):26586-26594. PMID: 27711392.
    View in: PubMed
  17. Xu WS, Luo PY, Sun L, Lin N. A Prediction Model of the Capillary Pressure J-Function. PLoS One. 2016; 11(9):e0162123. PMID: 27603701; PMCID: PMC5014314.
  18. Bychkovsky BL, Guo H, Sutton J, Spring L, Faig J, Dagogo-Jack I, Battelli C, Houlihan MJ, Yeh TC, Come SE, Lin NU. Use and Yield of Baseline Imaging and Laboratory Testing in Stage II Breast Cancer. Oncologist. 2016 Dec; 21(12):1495-1501. PMID: 27551013.
    View in: PubMed
  19. Vaz-Luis I, Lin NU, Keating NL, Barry WT, Lii J, Burstein HJ, Winer EP, Freedman RA. Treatment of early-stage human epidermal growth factor 2-positive cancers among medicare enrollees: age and race strongly associated with non-use of trastuzumab. Breast Cancer Res Treat. 2016 Aug; 159(1):151-62. PMID: 27484879.
    View in: PubMed
  20. Arvold ND, Lee EQ, Mehta MP, Margolin K, Alexander BM, Lin NU, Anders CK, Soffietti R, Camidge DR, Vogelbaum MA, Dunn IF, Wen PY. Updates in the management of brain metastases. Neuro Oncol. 2016 Aug; 18(8):1043-65. PMID: 27382120; PMCID: PMC4933491 [Available on 08/01/17].
  21. Kronzer VL, Tang RD, Schelble AP, Ben Abdallah A, Wildes TS, McKinnon SL, Sadiq F, Lin N, Helsten DL, Sharma A, Stark SL, Avidan MS. Preoperative Falls and Their Association with Functional Dependence and Quality of Life. Anesthesiology. 2016 Aug; 125(2):322-32. PMID: 27362869; PMCID: PMC5037058 [Available on 08/01/17].
  22. Bychkovsky BL, Lin NU. Imaging in the evaluation and follow-up of early and advanced breast cancer: When, why, and how often? Breast. 2017 Feb; 31:318-324. PMID: 27422453.
    View in: PubMed
  23. Shen G, Chen Y, Du W, Lin N, Wang X, Cheng H, Liu J, Xue C, Liu G, Zeng EY, Xing B, Tao S. Exposure and size distribution of nitrated and oxygenated polycyclic aromatic hydrocarbons among the population using different household fuels. Environ Pollut. 2016 Sep; 216:935-42. PMID: 27400906.
    View in: PubMed
  24. Ni J, Ramkissoon SH, Xie S, Goel S, Stover DG, Guo H, Luu V, Marco E, Ramkissoon LA, Kang YJ, Hayashi M, Nguyen QD, Ligon AH, Du R, Claus EB, Alexander BM, Yuan GC, Wang ZC, Iglehart JD, Krop IE, Roberts TM, Winer EP, Lin NU, Ligon KL, Zhao JJ. Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases. Nat Med. 2016 Jul; 22(7):723-6. PMID: 27270588; PMCID: PMC4938731 [Available on 12/06/16].
  25. Di Meglio A, Freedman RA, Lin NU, Barry WT, Metzger-Filho O, Keating NL, King TA, Sertoli MR, Boccardo F, Winer EP, Vaz-Luis I. Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis. Breast Cancer Res Treat. 2016 Jun; 157(3):587-96. PMID: 27271765.
    View in: PubMed
  26. Schwartz LH, Seymour L, Litière S, Ford R, Gwyther S, Mandrekar S, Shankar L, Bogaerts J, Chen A, Dancey J, Hayes W, Hodi FS, Hoekstra OS, Huang EP, Lin N, Liu Y, Therasse P, Wolchok JD, de Vries E. RECIST 1.1 - Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group. Eur J Cancer. 2016 Jul; 62:138-45. PMID: 27237360.
    View in: PubMed
  27. Schwartz LH, Litière S, de Vries E, Ford R, Gwyther S, Mandrekar S, Shankar L, Bogaerts J, Chen A, Dancey J, Hayes W, Hodi FS, Hoekstra OS, Huang EP, Lin N, Liu Y, Therasse P, Wolchok JD, Seymour L. RECIST 1.1-Update and clarification: From the RECIST committee. Eur J Cancer. 2016 Jul; 62:132-7. PMID: 27189322.
    View in: PubMed
  28. Chen Y, Du W, Shen G, Zhuo S, Zhu X, Shen H, Huang Y, Su S, Lin N, Pei L, Zheng X, Wu J, Duan Y, Wang X, Liu W, Wong M, Tao S. Household air pollution and personal exposure to nitrated and oxygenated polycyclic aromatics (PAHs) in rural households: Influence of household cooking energies. Indoor Air. 2017 Jan; 27(1):169-178. PMID: 27008622.
    View in: PubMed
  29. Tung N, Lin NU, Kidd J, Allen BA, Singh N, Wenstrup RJ, Hartman AR, Winer EP, Garber JE. Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer. J Clin Oncol. 2016 May 01; 34(13):1460-8. PMID: 26976419; PMCID: PMC4872307 [Available on 04/01/17].
  30. Lin N, Han R, Zhou J, Gelb AW. Mild Sedation Exacerbates or Unmasks Focal Neurologic Dysfunction in Neurosurgical Patients with Supratentorial Brain Mass Lesions in a Drug-specific Manner. Anesthesiology. 2016 Mar; 124(3):598-607. PMID: 26756518.
    View in: PubMed
  31. Ligibel JA, Giobbie-Hurder A, Shockro L, Campbell N, Partridge AH, Tolaney SM, Lin NU, Winer EP. Randomized trial of a physical activity intervention in women with metastatic breast cancer. Cancer. 2016 Apr 15; 122(8):1169-77. PMID: 26872302.
    View in: PubMed
  32. Vaz-Luis I, Hughes ME, Cronin A, Rugo HS, Edge SB, Moy B, Theriault RL, Hassett MJ, Winer EP, Lin NU. Trends in the use of mastectomy in women with small node-negative breast cancer treated at US academic centers. Breast Cancer Res Treat. 2016 Feb; 155(3):569-78. PMID: 26868124.
    View in: PubMed
  33. Freedman RA, Gelman RS, Wefel JS, Melisko ME, Hess KR, Connolly RM, Van Poznak CH, Niravath PA, Puhalla SL, Ibrahim N, Blackwell KL, Moy B, Herold C, Liu MC, Lowe A, Agar NY, Ryabin N, Farooq S, Lawler E, Rimawi MF, Krop IE, Wolff AC, Winer EP, Lin NU. Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases. J Clin Oncol. 2016 Mar 20; 34(9):945-52. PMID: 26834058.
    View in: PubMed
  34. Fritz BA, Kalarickal PL, Maybrier HR, Muench MR, Dearth D, Chen Y, Escallier KE, Ben Abdallah A, Lin N, Avidan MS. Intraoperative Electroencephalogram Suppression Predicts Postoperative Delirium. Anesth Analg. 2016 Jan; 122(1):234-42. PMID: 26418126; PMCID: PMC4684753 [Available on 01/01/17].
  35. Lin N, Zhou Y, Lian X, Tu Y. Expression of microRNA-106b and its clinical significance in cutaneous melanoma. Genet Mol Res. 2015 Dec 09; 14(4):16379-85. PMID: 26662433.
    View in: PubMed
  36. Cheng H, Liu P, Ohlson C, Xu E, Symonds L, Isabella A, Muller WJ, Lin NU, Krop IE, Roberts TM, Winer EP, Arteaga CL, Zhao JJ. PIK3CA(H1047R)- and Her2-initiated mammary tumors escape PI3K dependency by compensatory activation of MEK-ERK signaling. Oncogene. 2016 Jun 09; 35(23):2961-70. PMID: 26640141; PMCID: PMC4896860.
  37. Lin NU. Better treatments needed for breast cancer brain metastases. Lancet Oncol. 2015 Dec; 16(16):1583-4. PMID: 26596673.
    View in: PubMed
  38. Wang Q, Liu P, Spangle JM, Von T, Roberts TM, Lin NU, Krop IE, Winer EP, Zhao JJ. PI3K-p110a mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers. Oncogene. 2016 Jul 07; 35(27):3607-12. PMID: 26500061; PMCID: PMC4846581 [Available on 01/07/17].
  39. Brastianos PK, Carter SL, Santagata S, Cahill DP, Taylor-Weiner A, Jones RT, Van Allen EM, Lawrence MS, Horowitz PM, Cibulskis K, Ligon KL, Tabernero J, Seoane J, Martinez-Saez E, Curry WT, Dunn IF, Paek SH, Park SH, McKenna A, Chevalier A, Rosenberg M, Barker FG, Gill CM, Van Hummelen P, Thorner AR, Johnson BE, Hoang MP, Choueiri TK, Signoretti S, Sougnez C, Rabin MS, Lin NU, Winer EP, Stemmer-Rachamimov A, Meyerson M, Garraway L, Gabriel S, Lander ES, Beroukhim R, Batchelor TT, Baselga J, Louis DN, Getz G, Hahn WC. Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. Cancer Discov. 2015 Nov; 5(11):1164-77. PMID: 26410082; PMCID: PMC4916970.
  40. Golshan M, Losk K, Mallory MA, Camuso K, Troyan S, Lin NU, Kadish S, Bunnell CA. Variation in Additional Breast Imaging Orders and Impact on Surgical Wait Times at a Comprehensive Cancer Center. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S428-34. PMID: 26307233; PMCID: PMC4688062 [Available on 12/01/16].
  41. Li Z, Mao W, Lin N, Han S. Concurrent radiotherapy with S-1 plus cisplatin versus concurrent radiotherapy with cisplatin alone for the treatment of locally advanced cervical carcinoma: a pilot randomised controlled trial. Clin Transl Oncol. 2016 Apr; 18(4):413-7. PMID: 26304854.
    View in: PubMed
  42. Jiang J, Lin N, Guo S, Chen J, Xiong M. Multiple functional linear model for association analysis of RNA-seq with imaging. Quant Biol. 2015 Jun; 3(2):90-102. PMID: 26753102.
    View in: PubMed
  43. Seah DS, Scott S, Guo H, Najita J, Lederman R, Frank E, Sohl J, Stadler Z, Silverman S, Peppercorn J, Winer E, Come S, Lin NU. Variation in the Attitudes of Medical Oncologists Toward Research Biopsies in Patients With Metastatic Breast Cancer. Oncologist. 2015 Sep; 20(9):992-1000. PMID: 26240134; PMCID: PMC4571800.
  44. Mallory MA, Losk K, Lin NU, Sagara Y, Birdwell RL, Cutone L, Camuso K, Bunnell C, Aydogan F, Golshan M. The Influence of Radiology Image Consultation in the Surgical Management of Breast Cancer Patients. Ann Surg Oncol. 2015 Oct; 22(10):3383-8. PMID: 26202551; PMCID: PMC4648348 [Available on 10/01/16].
  45. Lin N, Jiang J, Guo S, Xiong M. Functional Principal Component Analysis and Randomized Sparse Clustering Algorithm for Medical Image Analysis. PLoS One. 2015; 10(7):e0132945. PMID: 26196383; PMCID: PMC4510534.
  46. Lin NU, Guo H, Yap JT, Mayer IA, Falkson CI, Hobday TJ, Dees EC, Richardson AL, Nanda R, Rimawi MF, Ryabin N, Najita JS, Barry WT, Arteaga CL, Wolff AC, Krop IE, Winer EP, Van den Abbeele AD. Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003). J Clin Oncol. 2015 Aug 20; 33(24):2623-31. PMID: 26169615; PMCID: PMC4534525 [Available on 08/20/16].
  47. Vaz-Luis I, Lin NU, Keating NL, Barry WT, Lii H, Winer EP, Freedman RA. Racial differences in outcomes for patients with metastatic breast cancer by disease subtype. Breast Cancer Res Treat. 2015 Jun; 151(3):697-707. PMID: 26022349.
    View in: PubMed
  48. Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG, Bendszus M, Brown PD, Camidge DR, Chang SM, Dancey J, de Vries EG, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wen PY. Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol. 2015 Jun; 16(6):e270-8. PMID: 26065612.
    View in: PubMed
  49. Shen G, Chen Y, Xue C, Lin N, Huang Y, Shen H, Wang Y, Li T, Zhang Y, Su S, Huangfu Y, Zhang W, Chen X, Liu G, Liu W, Wang X, Wong MH, Tao S. Pollutant emissions from improved coal- and wood-fuelled cookstoves in rural households. Environ Sci Technol. 2015 Jun 02; 49(11):6590-8. PMID: 25938574.
    View in: PubMed
  50. Chen Y, Shen G, Huang Y, Zhang Y, Han Y, Wang R, Shen H, Su S, Lin N, Zhu D, Pei L, Zheng X, Wu J, Wang X, Liu W, Wong M, Tao S. Household air pollution and personal exposure risk of polycyclic aromatic hydrocarbons among rural residents in Shanxi, China. Indoor Air. 2016 Apr; 26(2):246-58. PMID: 25808453.
    View in: PubMed
  51. Lin NU. Weighing the options for human epidermal growth factor receptor 2-directed therapy in metastatic breast cancer. J Clin Oncol. 2015 May 10; 33(14):1530-3. PMID: 25847924.
    View in: PubMed
  52. Paoletti C, Li Y, Muñiz MC, Kidwell KM, Aung K, Thomas DG, Brown ME, Abramson VG, Irvin WJ, Lin NU, Liu MC, Nanda R, Nangia JR, Storniolo AM, Traina TA, Vaklavas C, Van Poznak CH, Wolff AC, Forero-Torres A, Hayes DF. Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019. Clin Cancer Res. 2015 Jun 15; 21(12):2771-9. PMID: 25779948.
    View in: PubMed
  53. Forero-Torres A, Varley KE, Abramson VG, Li Y, Vaklavas C, Lin NU, Liu MC, Rugo HS, Nanda R, Storniolo AM, Traina TA, Patil S, Van Poznak CH, Nangia JR, Irvin WJ, Krontiras H, De Los Santos JF, Haluska P, Grizzle W, Myers RM, Wolff AC. TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer. Clin Cancer Res. 2015 Jun 15; 21(12):2722-9. PMID: 25779953.
    View in: PubMed
  54. Vaz-Luis I, Hughes ME, Cronin AM, Rugo HS, Edge SB, Moy B, Theriault RL, Hassett MJ, Winer EP, Lin NU. Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional study. Cancer. 2015 Jun 15; 121(12):1937-48. PMID: 25757412; PMCID: PMC4457605.
  55. Zeng Y, Zhang J, Zhu Y, Zhang J, Shen H, Lu J, Pan X, Lin N, Dai X, Zhou M, Chen X. Tripchlorolide improves cognitive deficits by reducing amyloid ß and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease. J Neurochem. 2015 Apr; 133(1):38-52. PMID: 25661995.
    View in: PubMed
  56. Jiang Y, Lin N, Huang S, Lin C, Jin N, Zhang Z, Ke J, Yu Y, Zhu J, Wang Y. Tracking nonpalpable breast cancer for breast-conserving surgery with carbon nanoparticles: implication in tumor location and lymph node dissection. Medicine (Baltimore). 2015 Mar; 94(10):e605. PMID: 25761181; PMCID: PMC4602461.
  57. Yao XG, Meng J, Zhou L, Lin N, Hong J, Heizhati M, Li NF. Relationship between polymorphism of SOCS-3 and dyslipidemia in China Xinjiang Uygur. Genet Mol Res. 2015 Feb 13; 14(1):1338-46. PMID: 25730073.
    View in: PubMed
  58. Li W, Wang C, Shen H, Su S, Shen G, Huang Y, Zhang Y, Chen Y, Chen H, Lin N, Zhuo S, Zhong Q, Wang X, Liu J, Li B, Liu W, Tao S. Concentrations and origins of nitro-polycyclic aromatic hydrocarbons and oxy-polycyclic aromatic hydrocarbons in ambient air in urban and rural areas in northern China. Environ Pollut. 2015 Feb; 197:156-64. PMID: 25528449.
    View in: PubMed
  59. Whitesell L, Santagata S, Mendillo ML, Lin NU, Proia DA, Lindquist S. HSP90 empowers evolution of resistance to hormonal therapy in human breast cancer models. Proc Natl Acad Sci U S A. 2014 Dec 23; 111(51):18297-302. PMID: 25489079; PMCID: PMC4280614.
  60. Zhou B, Shen H, Huang Y, Li W, Chen H, Zhang Y, Su S, Chen Y, Lin N, Zhuo S, Zhong Q, Liu J, Li B, Tao S. Daily variations of size-segregated ambient particulate matter in Beijing. Environ Pollut. 2015 Feb; 197:36-42. PMID: 25489748.
    View in: PubMed
  61. Li D, Ding J, Chen Z, Chen Y, Lin N, Chen F, Wang X. Accurately mapping the location of the binding site for the interaction between hepatitis B virus X protein and cytochrome c oxidase III. Int J Mol Med. 2015 Feb; 35(2):319-24. PMID: 25483779; PMCID: PMC4292715.
  62. Vaz-Luis I, Lin NU. Reply to H.L. McArthur et al. J Clin Oncol. 2015 Jan 01; 33(1):125. PMID: 25403214.
    View in: PubMed
  63. Huang Y, Shen H, Chen H, Wang R, Zhang Y, Su S, Chen Y, Lin N, Zhuo S, Zhong Q, Wang X, Liu J, Li B, Liu W, Tao S. Quantification of global primary emissions of PM2.5, PM10, and TSP from combustion and industrial process sources. Environ Sci Technol. 2014 Dec 02; 48(23):13834-43. PMID: 25347079.
    View in: PubMed
  64. Krop IE, Lin NU, Blackwell K, Guardino E, Huober J, Lu M, Miles D, Samant M, Welslau M, Diéras V. Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA. Ann Oncol. 2015 Jan; 26(1):113-9. PMID: 25355722.
    View in: PubMed
  65. Hergrueter CA, Camuso K, Lin NU, Cutone L, Hirshfield-Bartek J, Roberts P, Runkle W, Kadish S, Losk K, Bunnell CA. Standardizing coordination between surgical oncology and reconstructive surgery for breast cancer patients undergoing mastectomy with immediate reconstruction. J Clin Oncol. 2014 Oct 20; 32(30_suppl):110. PMID: 28141361.
    View in: PubMed
  66. Shen H, Tao S, Liu J, Huang Y, Chen H, Li W, Zhang Y, Chen Y, Su S, Lin N, Xu Y, Li B, Wang X, Liu W. Global lung cancer risk from PAH exposure highly depends on emission sources and individual susceptibility. Sci Rep. 2014 Oct 09; 4:6561. PMID: 25297709; PMCID: PMC4190535.
  67. Golshan M, Losk K, Kadish S, Lin NU, Hirshfield-Bartek J, Cutone L, Sagara Y, Aydogan F, Camuso K, Weingart SN, Bunnell C. Understanding process-of-care delays in surgical treatment of breast cancer at a comprehensive cancer center. Breast Cancer Res Treat. 2014 Nov; 148(1):125-33. PMID: 25270121.
    View in: PubMed
  68. Li D, Chen Z, Chen Y, Lin N, Wang X. [Location of the binding position for HBV X protein functional interaction with cytochrome C oxidase III]. Zhonghua Gan Zang Bing Za Zhi. 2014 Oct; 22(10):725-30. PMID: 25496859.
    View in: PubMed
  69. Wan HY, Kong XY, Li XM, Zhu HW, Su XH, Lin N. [Effect of traditional Chinese medicines with different properties on thermoregulation and temperature-sensitive transient receptor potentialion channel protein of rats with yeast-induced fever]. Zhongguo Zhong Yao Za Zhi. 2014 Oct; 39(19):3813-8. PMID: 25612446.
    View in: PubMed
  70. Seah DS, Lin NU, Curley C, Weiner EP, Partridge AH. Informational needs and the quality of life of patients in their first year after metastatic breast cancer diagnosis. J Community Support Oncol. 2014 Oct; 12(10):347-54. PMID: 25853256.
    View in: PubMed
  71. Kaiser HA, Ben Abdallah A, Lin N, Tellor BR, Helwani M, Smith JR, Moon MR, Avidan MS. Contaminated heparin and outcomes after cardiac surgery: a retrospective propensity-matched cohort study. PLoS One. 2014; 9(8):e106096. PMID: 25162640; PMCID: PMC4146562.
  72. Zhou Y, Lin N, Zhang B. An iteration normalization and test method for differential expression analysis of RNA-seq data. BioData Min. 2014; 7:15. PMID: 25285156; PMCID: PMC4181730.
  73. Rajakesari S, Arvold ND, Jimenez RB, Christianson LW, Horvath MC, Claus EB, Golby AJ, Johnson MD, Dunn IF, Lee EQ, Lin NU, Friesen S, Mannarino EG, Wagar M, Hacker FL, Weiss SE, Alexander BM. Local control after fractionated stereotactic radiation therapy for brain metastases. J Neurooncol. 2014 Nov; 120(2):339-46. PMID: 25059451.
    View in: PubMed
  74. Anders C, Deal AM, Abramson V, Liu MC, Storniolo AM, Carpenter JT, Puhalla S, Nanda R, Melhem-Bertrandt A, Lin NU, Kelly Marcom P, Van Poznak C, Stearns V, Melisko M, Smith JK, Karginova O, Parker J, Berg J, Winer EP, Peterman A, Prat A, Perou CM, Wolff AC, Carey LA. TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases. Breast Cancer Res Treat. 2014 Aug; 146(3):557-66. PMID: 25001612; PMCID: PMC4112043.
  75. Lim E, Lin NU. Updates on the management of breast cancer brain metastases. Oncology (Williston Park). 2014 Jul; 28(7):572-8. PMID: 25144276.
    View in: PubMed
  76. Shany-Ur T, Lin N, Rosen HJ, Sollberger M, Miller BL, Rankin KP. Self-awareness in neurodegenerative disease relies on neural structures mediating reward-driven attention. Brain. 2014 Aug; 137(Pt 8):2368-81. PMID: 24951639; PMCID: PMC4107746.
  77. Chen Y, Shen G, Su S, Shen H, Huang Y, Li T, Li W, Zhang Y, Lu Y, Chen H, Yang C, Lin N, Zhu Y, Fu X, Liu W, Wang X, Tao S. Contamination and distribution of parent, nitrated, and oxygenated polycyclic aromatic hydrocarbons in smoked meat. Environ Sci Pollut Res Int. 2014 Oct; 21(19):11521-30. PMID: 24910314.
    View in: PubMed
  78. Stratmann G, Lee J, Sall JW, Lee BH, Alvi RS, Shih J, Rowe AM, Ramage TM, Chang FL, Alexander TG, Lempert DK, Lin N, Siu KH, Elphick SA, Wong A, Schnair CI, Vu AF, Chan JT, Zai H, Wong MK, Anthony AM, Barbour KC, Ben-Tzur D, Kazarian NE, Lee JY, Shen JR, Liu E, Behniwal GS, Lammers CR, Quinones Z, Aggarwal A, Cedars E, Yonelinas AP, Ghetti S. Effect of general anesthesia in infancy on long-term recognition memory in humans and rats. Neuropsychopharmacology. 2014 Sep; 39(10):2275-87. PMID: 24910347; PMCID: PMC4168665.
  79. Li W, Wang C, Wang H, Chen J, Shen H, Shen G, Huang Y, Wang R, Wang B, Zhang Y, Chen H, Chen Y, Su S, Lin N, Tang J, Li Q, Wang X, Liu J, Tao S. Atmospheric polycyclic aromatic hydrocarbons in rural and urban areas of northern China. Environ Pollut. 2014 Sep; 192:83-90. PMID: 24905256.
    View in: PubMed
  80. Vaz-Luis I, Ottesen RA, Hughes ME, Mamet R, Burstein HJ, Edge SB, Gonzalez-Angulo AM, Moy B, Rugo HS, Theriault RL, Weeks JC, Winer EP, Lin NU. Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study. J Clin Oncol. 2014 Jul 10; 32(20):2142-50. PMID: 24888816; PMCID: PMC4076026.
  81. Wang R, Tao S, Shen H, Huang Y, Chen H, Balkanski Y, Boucher O, Ciais P, Shen G, Li W, Zhang Y, Chen Y, Lin N, Su S, Li B, Liu J, Liu W. Trend in global black carbon emissions from 1960 to 2007. Environ Sci Technol. 2014 Jun 17; 48(12):6780-7. PMID: 24825392.
    View in: PubMed
  82. Zhang Y, Lin N, Su S, Shen G, Chen Y, Yang C, Li W, Shen H, Huang Y, Chen H, Wang X, Liu W, Tao S. Freeze drying reduces the extractability of organochlorine pesticides in fish muscle tissue by microwave-assisted method. Environ Pollut. 2014 Aug; 191:250-2. PMID: 24838024.
    View in: PubMed
  83. Lu Y, Su S, Jin W, Wang B, Li N, Shen H, Li W, Huang Y, Chen H, Zhang Y, Chen Y, Lin N, Wang X, Tao S. Characteristics and cellular effects of ambient particulate matter from Beijing. Environ Pollut. 2014 Aug; 191:63-9. PMID: 24811947.
    View in: PubMed
  84. Giordano SH, Temin S, Kirshner JJ, Chandarlapaty S, Crews JR, Davidson NE, Esteva FJ, Gonzalez-Angulo AM, Krop I, Levinson J, Lin NU, Modi S, Patt DA, Perez EA, Perlmutter J, Ramakrishna N, Winer EP. Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2014 Jul 01; 32(19):2078-99. PMID: 24799465.
    View in: PubMed
  85. Ramakrishna N, Temin S, Chandarlapaty S, Crews JR, Davidson NE, Esteva FJ, Giordano SH, Gonzalez-Angulo AM, Kirshner JJ, Krop I, Levinson J, Modi S, Patt DA, Perez EA, Perlmutter J, Winer EP, Lin NU. Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2014 Jul 01; 32(19):2100-8. PMID: 24799487.
    View in: PubMed
  86. Freedman RA, Vaz-Luis I, Barry WT, Lii H, Lin NU, Winer EP, Keating NL. Patterns of chemotherapy, toxicity, and short-term outcomes for older women receiving adjuvant trastuzumab-based therapy. Breast Cancer Res Treat. 2014 Jun; 145(2):491-501. PMID: 24756187.
    View in: PubMed
  87. Niu Z, Lin N, Gu R, Sun Y, Feng Y. Associations between insulin resistance, free fatty acids, and oocyte quality in polycystic ovary syndrome during in vitro fertilization. J Clin Endocrinol Metab. 2014 Nov; 99(11):E2269-76. PMID: 24694334; PMCID: PMC4223443.
  88. Whitlock EL, Torres BA, Lin N, Helsten DL, Nadelson MR, Mashour GA, Avidan MS. Postoperative delirium in a substudy of cardiothoracic surgical patients in the BAG-RECALL clinical trial. Anesth Analg. 2014 Apr; 118(4):809-17. PMID: 24413548; PMCID: PMC4012920.
  89. Vaz-Luis I, Keating NL, Lin NU, Lii H, Winer EP, Freedman RA. Duration and toxicity of adjuvant trastuzumab in older patients with early-stage breast cancer: a population-based study. J Clin Oncol. 2014 Mar 20; 32(9):927-34. PMID: 24516021; PMCID: PMC3948095.
  90. Bunnell CA, Losk K, Kadish S, Lin N, Hirshfield-Bartek J, Cutone L, Camuso K, Golshan M, Weingart S. Measuring opportunities to improve timeliness of breast cancer care at Dana-Farber/Brigham and Women's Cancer Center. J Natl Compr Canc Netw. 2014 Feb; 12 Suppl 1:S5-9. PMID: 24614053.
    View in: PubMed
  91. Chen Y, Wang R, Shen H, Li W, Chen H, Huang Y, Zhang Y, Chen Y, Su S, Lin N, Liu J, Li B, Wang X, Liu W, Coveney RM, Tao S. Global mercury emissions from combustion in light of international fuel trading. Environ Sci Technol. 2014; 48(3):1727-35. PMID: 24433051.
    View in: PubMed
  92. Tang W, Pan J, Jiang N, Hu HY, Mahapatra T, Yin YP, Mahapatra S, Wang XL, Chen XS, Lin N, Zhang X, Huan XP, Yang HT, Fu GF. Correlates of chlamydia and gonorrhea infection among female sex workers: the untold story of Jiangsu, China. PLoS One. 2014; 9(1):e85985. PMID: 24454950; PMCID: PMC3893281.
  93. Guo M, Yap JT, Van den Abbeele AD, Lin NU, Schwartzman A. Voxelwise single-subject analysis of imaging metabolic response to therapy in neuro-oncology. Stat. 2014 Jan 01; 3(1):172-186. PMID: 24999285.
    View in: PubMed
  94. Lin NU. Targeted therapies in brain metastases. Curr Treat Options Neurol. 2014 Jan; 16(1):276. PMID: 24353011; PMCID: PMC3895218.
  95. Seah DS, Luis IV, Macrae E, Sohl J, Litsas G, Winer EP, Lin NU, Burstein HJ. Use and duration of chemotherapy in patients with metastatic breast cancer according to tumor subtype and line of therapy. J Natl Compr Canc Netw. 2014 Jan; 12(1):71-80. PMID: 24453294.
    View in: PubMed
  96. Thomssen C, Diel I, Gnant M, Goldmann-Posch U, Göschke C, Haidinger R, Janni W, Lin NU. Follow-up after breast cancer diagnosis. Breast Care (Basel). 2013 Dec; 8(6):457-60. PMID: 24550757; PMCID: PMC3919482.
  97. Lin NU, Amiri-Kordestani L, Palmieri D, Liewehr DJ, Steeg PS. CNS metastases in breast cancer: old challenge, new frontiers. Clin Cancer Res. 2013 Dec 01; 19(23):6404-18. PMID: 24298071.
    View in: PubMed
  98. Aranake A, Gradwohl S, Ben-Abdallah A, Lin N, Shanks A, Helsten DL, Glick DB, Jacobsohn E, Villafranca AJ, Evers AS, Avidan MS, Mashour GA. Increased risk of intraoperative awareness in patients with a history of awareness. Anesthesiology. 2013 Dec; 119(6):1275-83. PMID: 24113645.
    View in: PubMed
  99. Lin NU, Freedman RA, Ramakrishna N, Younger J, Storniolo AM, Bellon JR, Come SE, Gelman RS, Harris GJ, Henderson MA, Macdonald SM, Mahadevan A, Eisenberg E, Ligibel JA, Mayer EL, Moy B, Eichler AF, Winer EP. A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases. Breast Cancer Res Treat. 2013 Nov; 142(2):405-14. PMID: 24197661.
    View in: PubMed
  100. Kadish S, Golshan M, Lin N, Hirshfield-Bartek J, Cutone L, Bunnell CA, Weingart S. Reducing breast cancer chemotherapy treatment delays by improving the transition from surgical to medical oncology. J Clin Oncol. 2013 Nov; 31(31_suppl):51. PMID: 28136334.
    View in: PubMed
  101. Lin N, Ai TB, Gao JH, Fan LH, Wang SH, Chen F. Identification of novel acyl-ACP thioesterase gene ClFATB1 from Cinnamomum longepaniculatum. Biochemistry (Mosc). 2013 Nov; 78(11):1298-303. PMID: 24460945.
    View in: PubMed
  102. Zhang Y, Ding J, Shen G, Zhong J, Wang C, Wei S, Chen C, Chen Y, Lu Y, Shen H, Li W, Huang Y, Chen H, Su S, Lin N, Wang X, Liu W, Tao S. Dietary and inhalation exposure to polycyclic aromatic hydrocarbons and urinary excretion of monohydroxy metabolites--a controlled case study in Beijing, China. Environ Pollut. 2014 Jan; 184:515-22. PMID: 24177434; PMCID: PMC4299857.
  103. Zhang Y, Wang R, Li S, Kong X, Wang Z, Chen W, Lin N. Genetic polymorphisms in plasminogen activator inhibitor-1 predict susceptibility to steroid-induced osteonecrosis of the femoral head in Chinese population. Diagn Pathol. 2013 Oct 17; 8:169. PMID: 24135164; PMCID: PMC4016530.
  104. Lin N, Pan XD, Chen AQ, Zhu YG, Wu M, Zhang J, Chen XC. Tripchlorolide improves age-associated cognitive deficits by reversing hippocampal synaptic plasticity impairment and NMDA receptor dysfunction in SAMP8 mice. Behav Brain Res. 2014 Jan 01; 258:8-18. PMID: 24140565.
    View in: PubMed
  105. Vaz-Luis I, Zeghibe CA, Frank ES, Sohl J, Washington KE, Silverman SG, Fonte JM, Mayer EL, Overmoyer BA, Richardson AL, Krop IE, Winer EP, Lin NU. Prospective clinical experience with research biopsies in breast cancer patients. Breast Cancer Res Treat. 2013 Nov; 142(1):203-9. PMID: 24113744; PMCID: PMC3825285.
  106. Zhang J, Yang L, Lin N, Pan X, Zhu Y, Chen X. Aging-related changes in RP3V kisspeptin neurons predate the reduced activation of GnRH neurons during the early reproductive decline in female mice. Neurobiol Aging. 2014 Mar; 35(3):655-68. PMID: 24112790.
    View in: PubMed
  107. Morris PG, Patil S, Chen C, Abbruzzi A, Lehman RJ, Steingart R, Oeffinger KC, Lin NU, Moy B, Come SE, Winer EP, Norton L, Hudis C, Dang CT. Longer-term cardiac safety and outcomes of dose dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC). J Clin Oncol. 2013 Sep 10; 31(26_suppl):167. PMID: 28136572.
    View in: PubMed
  108. Lin NU, Wefel JS, Lee EQ, Schiff D, van den Bent MJ, Soffietti R, Suh JH, Vogelbaum MA, Mehta MP, Dancey J, Linskey ME, Camidge DR, Aoyama H, Brown PD, Chang SM, Kalkanis SN, Barani IJ, Baumert BG, Gaspar LE, Hodi FS, Macdonald DR, Wen PY. Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group. Lancet Oncol. 2013 Sep; 14(10):e407-16. PMID: 23993385.
    View in: PubMed
  109. Lin NU, Lee EQ, Aoyama H, Barani IJ, Baumert BG, Brown PD, Camidge DR, Chang SM, Dancey J, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Lamborn KR, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wefel JS, Wen PY. Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group. Lancet Oncol. 2013 Sep; 14(10):e396-406. PMID: 23993384.
    View in: PubMed
  110. Morris PG, Iyengar NM, Patil S, Chen C, Abbruzzi A, Lehman R, Steingart R, Oeffinger KC, Lin N, Moy B, Come SE, Winer EP, Norton L, Hudis CA, Dang CT. Long-term cardiac safety and outcomes of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab with and without lapatinib in patients with early breast cancer. Cancer. 2013 Nov 15; 119(22):3943-51. PMID: 24037735.
    View in: PubMed
  111. Vaz-Luis I, Seah D, Olson EM, Wagle N, Metzger-Filho O, Sohl J, Litsas G, Burstein HJ, Krop IE, Winer EP, Lin NU. Clinicopathological features among patients with advanced human epidermal growth factor-2-positive breast cancer with prolonged clinical benefit to first-line trastuzumab-based therapy: a retrospective cohort study. Clin Breast Cancer. 2013 Aug; 13(4):254-63. PMID: 23829891; PMCID: PMC4084778.
  112. Chen WH, Zhou Y, He HJ, Liu DB, Wang ZY, Wang RT, Lin N. [Treating early-to-middle stage nontraumatic osteonecrosis of femoral head patients by jianpi huogu recipe: a retrospective study]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013 Aug; 33(8):1054-8. PMID: 24325053.
    View in: PubMed
  113. Lin N, Moon TS, Stratmann G, Sall JW. Biphasic change of progenitor proliferation in dentate gyrus after single dose of isoflurane in young adult rats. J Neurosurg Anesthesiol. 2013 Jul; 25(3):306-10. PMID: 23752046; PMCID: PMC3682229.
  114. Zhang B, Zhou Y, Lin N, Lowdon RF, Hong C, Nagarajan RP, Cheng JB, Li D, Stevens M, Lee HJ, Xing X, Zhou J, Sundaram V, Elliott G, Gu J, Shi T, Gascard P, Sigaroudinia M, Tlsty TD, Kadlecek T, Weiss A, O'Geen H, Farnham PJ, Maire CL, Ligon KL, Madden PA, Tam A, Moore R, Hirst M, Marra MA, Zhang B, Costello JF, Wang T. Functional DNA methylation differences between tissues, cell types, and across individuals discovered using the M&M algorithm. Genome Res. 2013 Sep; 23(9):1522-40. PMID: 23804400; PMCID: PMC3759728.
  115. Mayer EL, Lin NU. Reply to V. Pitini et al. J Clin Oncol. 2013 Jun 10; 31(17):2225-6. PMID: 23901420.
    View in: PubMed
  116. Lin NU, Seah DS, Gelman R, Desantis S, Mayer EL, Isakoff S, Dipiro P, Krop IE, Come SE, Weckstein D, Winer EP, Burstein HJ. A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancer. Breast Cancer Res Treat. 2013 Jun; 139(2):403-10. PMID: 23645007.
    View in: PubMed
  117. Xu Y, Liu CF, Wang YW, Yang B, Li XL, Qiao L, Lin N. Water decoction of coptidis rhizoma prevents oxidative damage in erythrocytes of mice. Indian J Pharm Sci. 2013 May; 75(3):270-6. PMID: 24082342; PMCID: PMC3783744.
  118. Lin NU. Breast cancer brain metastases: new directions in systemic therapy. Ecancermedicalscience. 2013; 7:307. PMID: 23662165; PMCID: PMC3646423.
  119. Lin NU, Thomssen C, Cardoso F, Cameron D, Cufer T, Fallowfield L, Francis PA, Kyriakides S, Pagani O, Senkus E, Costa A, Winer EP. International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)-MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer. Breast. 2013 Jun; 22(3):203-10. PMID: 23601761.
    View in: PubMed
  120. Modi S, Saura C, Henderson C, Lin NU, Mahtani R, Goddard J, Rodenas E, Hudis C, O'Shaughnessy J, Baselga J. A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer. Breast Cancer Res Treat. 2013 May; 139(1):107-13. PMID: 23580070; PMCID: PMC3646160.
  121. Nahleh ZA, Lin NU, Wolff AC, Cardoso F. Perceptions and needs of women with metastatic breast cancer: a focus on clinical trials. Breast. 2013 Jun; 22(3):370-3. PMID: 23535510; PMCID: PMC3978177.
  122. Seah DS, Scott SM, Najita J, Openshaw T, Krag K, Frank E, Sohl J, Stadler ZK, Garrett M, Silverman SG, Peppercorn J, Winer EP, Come SE, Lin NU. Attitudes of patients with metastatic breast cancer toward research biopsies. Ann Oncol. 2013 Jul; 24(7):1853-9. PMID: 23493137.
    View in: PubMed
  123. Sperduto PW, Kased N, Roberge D, Chao ST, Shanley R, Luo X, Sneed PK, Suh J, Weil RJ, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, Sperduto CM, Lin N, Mehta M. The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer. J Neurooncol. 2013 May; 112(3):467-72. PMID: 23462853.
    View in: PubMed
  124. Olson EM, Abdel-Rasoul M, Maly J, Wu CS, Lin NU, Shapiro CL. Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumab. Ann Oncol. 2013 Jun; 24(6):1526-33. PMID: 23463626; PMCID: PMC3660080.
  125. Lin NU. Brain metastases in HER2-positive breast cancer. Lancet Oncol. 2013 Mar; 14(3):185-6. PMID: 23414590.
    View in: PubMed
  126. Olson EM, Najita JS, Sohl J, Arnaout A, Burstein HJ, Winer EP, Lin NU. Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab era. Breast. 2013 Aug; 22(4):525-31. PMID: 23352568; PMCID: PMC3713786.
  127. Guo H, Lin N, Chen Y, Wang Z, Xie Q, Zheng T, Gao N, Li S, Kang J, Cai D, Peng DL. Copper nanowires as fully transparent conductive electrodes. Sci Rep. 2013; 3:2323. PMID: 23900572; PMCID: PMC3728602.
  128. Duggineni S, Mitra S, Noberini R, Han X, Lin N, Xu Y, Tian W, An J, Pasquale EB, Huang Z. Design, synthesis and characterization of novel small molecular inhibitors of ephrin-B2 binding to EphB4. Biochem Pharmacol. 2013 Feb 15; 85(4):507-13. PMID: 23253822; PMCID: PMC3807243.
  129. Preusser M, Berghoff AS, Schadendorf D, Lin NU, Stupp R. Brain metastasis: opportunity for drug development? Curr Opin Neurol. 2012 Dec; 25(6):786-94. PMID: 23108247.
    View in: PubMed
  130. Ma H, Sinha B, Pandya RS, Lin N, Popp AJ, Li J, Yao J, Wang X. Therapeutic hypothermia as a neuroprotective strategy in neonatal hypoxic-ischemic brain injury and traumatic brain injury. Curr Mol Med. 2012 Dec; 12(10):1282-96. PMID: 22834830; PMCID: PMC4173077.
  131. Sperduto PW, Sneed PK, Roberge D, Shanley R, Luo X, Luo X, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Knisely JP, Lin N, Mehta M. In regard to Yamamoto et al. Int J Radiat Oncol Biol Phys. 2012 Nov 15; 84(4):875-6; discussion 876-7. PMID: 23078894.
    View in: PubMed
  132. Whitesell L, Santagata S, Lin NU. Inhibiting HSP90 to treat cancer: a strategy in evolution. Curr Mol Med. 2012 Nov 01; 12(9):1108-24. PMID: 22804235.
    View in: PubMed
  133. Vaz-Luis I, Ottesen RA, Hughes ME, Marcom PK, Moy B, Rugo HS, Theriault RL, Wilson J, Niland JC, Weeks JC, Lin NU. Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study. Breast Cancer Res. 2012 Oct 01; 14(5):R129. PMID: 23025714; PMCID: PMC4053106.
  134. Vaz-Luis I, Winer EP, Lin NU. Human epidermal growth factor receptor-2-positive breast cancer: does estrogen receptor status define two distinct subtypes? Ann Oncol. 2013 Feb; 24(2):283-91. PMID: 23022997; PMCID: PMC3551479.
  135. Mayer EL, Lin NU. Long term follow-up of national surgical adjuvant breast and bowel project trial B-31: how well can we predict cardiac toxicity with trastuzumab? J Clin Oncol. 2012 Nov 01; 30(31):3769-72. PMID: 22987088.
    View in: PubMed
  136. Arvold ND, Oh KS, Niemierko A, Taghian AG, Lin NU, Abi-Raad RF, Sreedhara M, Harris JR, Alexander BM. Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype. Breast Cancer Res Treat. 2012 Nov; 136(1):153-60. PMID: 22968656.
    View in: PubMed
  137. Preusser M, Winkler F, Collette L, Haller S, Marreaud S, Soffietti R, Klein M, Reijneveld JC, Tonn JC, Baumert BG, Mulvenna P, Schadendorf D, Duchnowska R, Berghoff AS, Lin N, Cameron DA, Belkacemi Y, Jassem J, Weber DC. Trial design on prophylaxis and treatment of brain metastases: lessons learned from the EORTC Brain Metastases Strategic Meeting 2012. Eur J Cancer. 2012 Dec; 48(18):3439-47. PMID: 22883982.
    View in: PubMed
  138. Dyer MA, Kelly PJ, Chen YH, Pinnell NE, Claus EB, Lee EQ, Weiss SE, Arvold ND, Lin NU, Alexander BM. Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases. Int J Radiat Oncol Biol Phys. 2012 Jul 15; 83(4):e479-86. PMID: 22704705.
    View in: PubMed
  139. Lim E, Lin NU. New insights and emerging therapies for breast cancer brain metastases. Oncology (Williston Park). 2012 Jul; 26(7):652-9, 663. PMID: 22888567.
    View in: PubMed
  140. Joffe H, Deckersbach T, Lin NU, Makris N, Skaar TC, Rauch SL, Dougherty DD, Hall JE. Metabolic activity in the insular cortex and hypothalamus predicts hot flashes: an FDG-PET study. J Clin Endocrinol Metab. 2012 Sep; 97(9):3207-15. PMID: 22723326; PMCID: PMC3791433.
  141. Lin NU, Vanderplas A, Hughes ME, Theriault RL, Edge SB, Wong YN, Blayney DW, Niland JC, Winer EP, Weeks JC. Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network. Cancer. 2012 Nov 15; 118(22):5463-72. PMID: 22544643; PMCID: PMC3611659.
  142. Meisel JL, Domchek SM, Vonderheide RH, Giobbie-Hurder A, Lin NU, Winer EP, Partridge AH. Quality of life in long-term survivors of metastatic breast cancer. Clin Breast Cancer. 2012 Apr; 12(2):119-26. PMID: 22444718.
    View in: PubMed
  143. Cardoso F, Costa A, Norton L, Cameron D, Cufer T, Fallowfield L, Francis P, Gligorov J, Kyriakides S, Lin N, Pagani O, Senkus E, Thomssen C, Aapro M, Bergh J, Di Leo A, El Saghir N, Ganz PA, Gelmon K, Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Leadbeater M, Mayer M, Rodger A, Rugo H, Sacchini V, Sledge G, van't Veer L, Viale G, Krop I, Winer E. 1st International consensus guidelines for advanced breast cancer (ABC 1). Breast. 2012 Jun; 21(3):242-52. PMID: 22425534.
    View in: PubMed
  144. Lin NU, Winer EP, Wheatley D, Carey LA, Houston S, Mendelson D, Munster P, Frakes L, Kelly S, Garcia AA, Cleator S, Uttenreuther-Fischer M, Jones H, Wind S, Vinisko R, Hickish T. A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab. Breast Cancer Res Treat. 2012 Jun; 133(3):1057-65. PMID: 22418700; PMCID: PMC3387495.
  145. Parks GK, Lee E, McCarthy M, Goldstein M, Fu SY, Cao JB, Canu P, Lin N, Wilber M, Dandouras I, Réme H, Fazakerley A. Entropy generation across Earth's collisionless bow shock. Phys Rev Lett. 2012 Feb 10; 108(6):061102. PMID: 22401049.
    View in: PubMed
  146. Mao Y, Lin N, Tian W, Han X, Han X, Huang Z, An J. Design, synthesis, and biological evaluation of new diaminoquinazolines as ß-catenin/Tcf4 pathway inhibitors. J Med Chem. 2012 Feb 09; 55(3):1346-59. PMID: 22229647.
    View in: PubMed
  147. Olson EM, Lin NU, Krop IE, Winer EP. Author's reply: Use of discard pleural fluid in molecular research. Nat Rev Clin Oncol. 2012 Jan; 9(1). PMID: 24222788.
    View in: PubMed
  148. Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, Sperduto CM, Lin N, Mehta M. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol. 2012 Feb 01; 30(4):419-25. PMID: 22203767; PMCID: PMC3269967.
  149. Whitesell L, Lin NU. HSP90 as a platform for the assembly of more effective cancer chemotherapy. Biochim Biophys Acta. 2012 Mar; 1823(3):756-66. PMID: 22222203.
    View in: PubMed
  150. Santagata S, Hu R, Lin NU, Mendillo ML, Collins LC, Hankinson SE, Schnitt SJ, Whitesell L, Tamimi RM, Lindquist S, Ince TA. High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer. Proc Natl Acad Sci U S A. 2011 Nov 08; 108(45):18378-83. PMID: 22042860; PMCID: PMC3215027.
  151. Kelly PJ, Lin NU, Claus EB, Quant EC, Weiss SE, Alexander BM. Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors. Cancer. 2012 Apr 15; 118(8):2014-20. PMID: 21918959.
    View in: PubMed
  152. Olson EM, Lin NU, Krop IE, Winer EP. The ethical use of mandatory research biopsies. Nat Rev Clin Oncol. 2011 08 02; 8(10):620-5. PMID: 21808265; PMCID: PMC3632075.
  153. Lin NU, Eierman W, Greil R, Campone M, Kaufman B, Steplewski K, Lane SR, Zembryki D, Rubin SD, Winer EP. Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases. J Neurooncol. 2011 Dec; 105(3):613-20. PMID: 21706359.
    View in: PubMed
  154. Freedman RA, Bullitt E, Sun L, Gelman R, Harris G, Ligibel JA, Krop IE, Partridge AH, Eisenberg E, Winer EP, Lin NU. A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases. Clin Breast Cancer. 2011 Dec; 11(6):376-83. PMID: 21697017; PMCID: PMC3773692.
  155. Wo JY, Chen K, Neville BA, Lin NU, Punglia RS. Effect of very small tumor size on cancer-specific mortality in node-positive breast cancer. J Clin Oncol. 2011 Jul 01; 29(19):2619-27. PMID: 21606424; PMCID: PMC3139369.
  156. Olson EM, Najita JS, Sohl J, Arnaout A, Winer EP, Lin NU. Predictors of survival in patients with HER2+ metastatic breast cancer (MBC) treated with trastuzumab. J Clin Oncol. 2011 May 20; 29(15_suppl):e11100. PMID: 28024068.
    View in: PubMed
  157. Forero-Torres A, Lin NU, Liu MC, Rugo HS, Puhalla S, Nanda R, Mayer IA, Storniolo AM, Traina TA, Hayes DF, Rimawi MF, Goetz MP, Esteva FJ, Irvin WJ, Wolff AC. TBCRC 019: An open-label, randomized, phase II trial of nanoparticle albumin-bound paclitaxel with or without the anti-death receptor 5 (DR5) monoclonal antibody tigatuzumab in patients with metastatic, triple-negative (ER, PR, and HER2-negative) breast cancer. J Clin Oncol. 2011 May 20; 29(15_suppl):TPS128. PMID: 28022930.
    View in: PubMed
  158. Modi S, Saura C, Henderson CA, Lin NU, Mahtani RL, Goddard J, Rodenas E, O'Shaughnessy J, Baselga J. Efficacy and safety of retaspimycin hydrochloride (IPI-504) in combination with trastuzumab in patients (pts) with pretreated, locally advanced or metastatic HER2-positive breast cancer. J Clin Oncol. 2011 May 20; 29(15_suppl):590. PMID: 28021657.
    View in: PubMed
  159. Anders CK, Nanda R, Liu MC, Blackwell KL, Van Poznak CH, Abramson VG, Storniolo AM, Lin NU, Stearns V, Melhem A, Puhalla S, Carpenter JT, Melisko ME, Deal AM, Hudis C, Winer EP, Perou CM, Bradley CR, Wolff AC, Carey LA. TBCRC 018: Phase II study of iniparib plus chemotherapy to treat triple-negative breast cancer (TNBC) brain metastases (BM). J Clin Oncol. 2011 May 20; 29(15_suppl):TPS127. PMID: 28022927.
    View in: PubMed
  160. Kelly PJ, Lin NU, Claus EB, Weiss SE, Alexander BM. Salvage stereotactic radiosurgery (SRS) after previous whole-brain radiation therapy (WBRT) for breast cancer brain metastases: Outcomes and prognostic factors including tumor phenotype. J Clin Oncol. 2011 May 20; 29(15_suppl):581. PMID: 28021626.
    View in: PubMed
  161. Lin NU, Danso MA, David AK, Muscato JJ, Ellis CE, Lahiri S, Sessa T, Nagarwala YM, Winer E. HER2 suppression with the addition of lapatinib to trastuzumab in HER2-positive metastatic breast cancer (LPT112515). J Clin Oncol. 2011 May 20; 29(15_suppl):TPS113. PMID: 28022841.
    View in: PubMed
  162. Olson EM, Lin NU, DiPiro PJ, Najita JS, Krop IE, Winer EP, Burstein HJ. Responses to subsequent anti-HER2 therapy after treatment with trastuzumab-DM1 in women with HER2-positive metastatic breast cancer. Ann Oncol. 2012 Jan; 23(1):93-7. PMID: 21531783; PMCID: PMC3276325.
  163. Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, Sperduto CM, Lin N, Mehta M. Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases. Int J Radiat Oncol Biol Phys. 2012 Apr 01; 82(5):2111-7. PMID: 21497451; PMCID: PMC3172400.
  164. Wang F, Xu CQ, He Q, Cai JP, Li XC, Wang D, Xiong X, Liao YH, Zeng QT, Yang YZ, Cheng X, Li C, Yang R, Wang CC, Wu G, Lu QL, Bai Y, Huang YF, Yin D, Yang Q, Wang XJ, Dai DP, Zhang RF, Wan J, Ren JH, Li SS, Zhao YY, Fu FF, Huang Y, Li QX, Shi SW, Lin N, Pan ZW, Li Y, Yu B, Wu YX, Ke YH, Lei J, Wang N, Luo CY, Ji LY, Gao LJ, Li L, Liu H, Huang EW, Cui J, Jia N, Ren X, Li H, Ke T, Zhang XQ, Liu JY, Liu MG, Xia H, Yang B, Shi LS, Xia YL, Tu X, Wang QK. Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population. Nat Genet. 2011 Mar 06; 43(4):345-9. PMID: 21378986.
    View in: PubMed
  165. Morris PG, Chen C, Steingart R, Fleisher M, Lin N, Moy B, Come S, Sugarman S, Abbruzzi A, Lehman R, Patil S, Dickler M, McArthur HL, Winer E, Norton L, Hudis CA, Dang CT. Troponin I and C-reactive protein are commonly detected in patients with breast cancer treated with dose-dense chemotherapy incorporating trastuzumab and lapatinib. Clin Cancer Res. 2011 May 15; 17(10):3490-9. PMID: 21372222.
    View in: PubMed
  166. Lin NU, Burstein HJ. EMBRACE, eribulin, and new realities of advanced breast cancer. Lancet. 2011 Mar 12; 377(9769):878-80. PMID: 21376386.
    View in: PubMed
  167. Lin NU, Winer EP. Chemotherapy agents in human epidermal growth factor receptor 2-positive breast cancer: time to step out of the limelight. J Clin Oncol. 2011 Jan 20; 29(3):251-3. PMID: 21149664.
    View in: PubMed
  168. Yu L, Lee T, Lin N, Wolf MJ. Affecting Rhomboid-3 function causes a dilated heart in adult Drosophila. PLoS Genet. 2010 May 27; 6(5):e1000969. PMID: 20523889; PMCID: PMC2877733.
  169. Dang C, Lin N, Moy B, Come S, Sugarman S, Morris P, Abbruzzi A, Chen C, Steingart R, Patil S, Norton L, Winer E, Hudis C. Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrhea. J Clin Oncol. 2010 Jun 20; 28(18):2982-8. PMID: 20479410; PMCID: PMC3664034.
  170. Muenzer JT, Jaffe DM, Schwulst SJ, Dixon DJ, Schierding WS, Li Q, MacMillan SK, Oppedal D, Warner BW, Dillon PA, Lin N, Checchia PA, Cobb JP. Evidence for a novel blood RNA diagnostic for pediatric appendicitis: the riboleukogram. Pediatr Emerg Care. 2010 May; 26(5):333-8. PMID: 20404783.
    View in: PubMed
  171. Peppercorn J, Shapira I, Collyar D, Deshields T, Lin N, Krop I, Grunwald H, Friedman P, Partridge AH, Schilsky RL, Bertagnolli MM. Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology. J Clin Oncol. 2010 May 20; 28(15):2635-40. PMID: 20406927.
    View in: PubMed
  172. Toro C, De Boni L, Lin N, Santoro F, Rizzo A, Hernandez FE. Two-photon absorption circular dichroism: a new twist in nonlinear spectroscopy. Chemistry. 2010 Mar 15; 16(11):3504-9. PMID: 20162644.
    View in: PubMed
  173. Zhang B, Feng X, Wang J, Xu X, Liu H, Lin N. Adenovirus-mediated delivery of bFGF small interfering RNA increases levels of connexin 43 in the glioma cell line, U251. J Exp Clin Cancer Res. 2010 Jan 14; 29:3. PMID: 20074329; PMCID: PMC2830951.
  174. Lin NU. Concordance of HER2 in primary tumor and leptomeningeal metastases: now what? Breast Cancer Res Treat. 2010 Aug; 123(1):129-31. PMID: 20054640.
    View in: PubMed
  175. Morris PG, Dickler M, McArthur HL, Traina T, Sugarman S, Lin N, Moy B, Come S, Godfrey L, Nulsen B, Chen C, Steingart R, Rugo H, Norton L, Winer E, Hudis CA, Dang CT. Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction. J Clin Oncol. 2009 Dec 20; 27(36):6117-23. PMID: 19901120; PMCID: PMC3664032.
  176. Lin NU, Kasparian E, Morganstern DE, Beard C. Geographic distribution of lapatinib-induced skin rash: sparing of abdominal skin persists in the transverse rectus abdominis myocutaneous flap. J Clin Oncol. 2009 Dec 01; 27(34):e218-9. PMID: 19786662.
    View in: PubMed
  177. Lee E, Parks GK, Wilber M, Lin N. Nonlinear development of shocklike structure in the solar wind. Phys Rev Lett. 2009 Jul 17; 103(3):031101. PMID: 19659262.
    View in: PubMed
  178. Hickish T, Wheatley D, Lin N, Carey L, Houston S, Mendelson D, Solca F, Uttenreuther-Fischer M, Jones H, Winer E. Use of BIBW 2992, a novel irreversible EGFR/HER2 tyrosine kinase inhibitor (TKI), to treat patients with HER2-positive metastatic breast cancer after failure of treatment with trastuzumab. J Clin Oncol. 2009 May 20; 27(15_suppl):1023. PMID: 27961052.
    View in: PubMed
  179. Lin NU, Vanderplas A, Hughes ME, Theriault RL, Edge SB, Wong Y, Blayney DW, Niland JC, Winer EP, Weeks JC. Clinicopathological features and sites of recurrence according to breast cancer subtype in the National Comprehensive Cancer Network (NCCN). J Clin Oncol. 2009 May 20; 27(15_suppl):543. PMID: 27960656.
    View in: PubMed
  180. Ruddy KJ, Gelber S, Tamimi R, Schapira L, Come S, Kereakoglow S, Lin NU, Winer EP, Partridge AH. Presentation of breast cancer in young women. J Clin Oncol. 2009 May 20; 27(15_suppl):6608. PMID: 27961738.
    View in: PubMed
  181. Lin NU, Diéras V, Paul D, Lossignol D, Christodoulou C, Stemmler HJ, Roché H, Liu MC, Greil R, Ciruelos E, Loibl S, Gori S, Wardley A, Yardley D, Brufsky A, Blum JL, Rubin SD, Dharan B, Steplewski K, Zembryki D, Oliva C, Roychowdhury D, Paoletti P, Winer EP. Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer. Clin Cancer Res. 2009 Feb 15; 15(4):1452-9. PMID: 19228746.
    View in: PubMed
  182. Li K, He W, Lin N, Wang X, Fan QX. N-cadherin knock-down decreases invasiveness of esophageal squamous cell carcinoma in vitro. World J Gastroenterol. 2009 Feb 14; 15(6):697-704. PMID: 19222093; PMCID: PMC2653438.
  183. Lin NU, Claus E, Sohl J, Razzak AR, Arnaout A, Winer EP. Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases. Cancer. 2008 Nov 15; 113(10):2638-45. PMID: 18833576; PMCID: PMC2835546.
  184. Chen RC, Lin NU, Golshan M, Harris JR, Bellon JR. Internal mammary nodes in breast cancer: diagnosis and implications for patient management -- a systematic review. J Clin Oncol. 2008 Oct 20; 26(30):4981-9. PMID: 18711171.
    View in: PubMed
  185. Lin NU, Roché HH, Dieras V, Skarlos D, Stemmler HJ, Liu M, Dharan B, Zembryki D, Stepewski K, Rubin SD. A physician-reported neurological signs and symptoms worksheet (NSS WS) in EGF105084: A phase II study of lapatinib (lap) for pts with recurrent brain metastases (BM) from HER2+ breast cancer (BC). J Clin Oncol. 2008 May 20; 26(15_suppl):1078. PMID: 27951070.
    View in: PubMed
  186. Dang CT, Lin NU, Lake D, Dickler MN, Modi S, Seidman AD, Steingart RM, Norton L, Winer EP, Hudis CA. Preliminary safety results of dose-dense (dd) doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (P) with trastuzumab (T) and lapatinib (L) in HER2 overexpressed/amplified breast cancer (BCA). J Clin Oncol. 2008 May 20; 26(15_suppl):518. PMID: 27948552.
    View in: PubMed
  187. Lin NU, Carey LA, Liu MC, Younger J, Come SE, Ewend M, Harris GJ, Bullitt E, Van den Abbeele AD, Henson JW, Li X, Gelman R, Burstein HJ, Kasparian E, Kirsch DG, Crawford A, Hochberg F, Winer EP. Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer. J Clin Oncol. 2008 Apr 20; 26(12):1993-9. PMID: 18421051; PMCID: PMC4524351.
  188. Lin NU, Winer EP. Optimizing endocrine therapy for estrogen receptor-positive breast cancer: treating the right patients for the right length of time. J Clin Oncol. 2008 Apr 20; 26(12):1919-21. PMID: 18332468.
    View in: PubMed
  189. Lin NU, Winer EP. Advances in adjuvant endocrine therapy for postmenopausal women. J Clin Oncol. 2008 Feb 10; 26(5):798-805. PMID: 18258989.
    View in: PubMed
  190. Liu MC, Demetri GD, Berry DA, Norton L, Broadwater G, Robert NJ, Duggan D, Hayes DF, Henderson IC, Lyss A, Hopkins J, Kaufman PA, Marcom PK, Younger J, Lin N, Tkaczuk K, Winer EP, Hudis CA. Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxel. Cancer Treat Rev. 2008 May; 34(3):223-30. PMID: 18234424; PMCID: PMC2651678.
  191. Razzak AR, Lin NU, Winer EP. Heterogeneity of breast cancer and implications of adjuvant chemotherapy. Breast Cancer. 2008; 15(1):31-4. PMID: 18224391.
    View in: PubMed
  192. Lin NU. Treatment of HER2-positive breast cancer: new approaches, new opportunities. Breast Dis Quart. 2008; 18(4):336-338.
  193. Lin NU, Paul D, Dieras V, Liu M, Greil R, Roche H, Rubin SD, Zembryki D, Oliva C, Jayawardene D, Winer EP. Lapatinib and capecitabine for the treatment of brain metastases in patients with HER2+ breast cancer--an updated analysis from EGF105084. Breast Cancer Res Treat. 2007; 106(Suppl 1):Abstract 6076.
  194. Mayer EL, Hamel S, Savoie J, Parker LM, Lin NU, Anderson K, Heymach JV, Gelman R, Ivy SP, Winer EP, Burstein HJ. AZD2171 for refractory breast cancer: a phase 2 trial. Breast Cancer Res Treat. 2007; 106(Suppl 1):Abstract 6080.
  195. Bullitt E, Lin NU, Smith JK, Zeng D, Winer EP, Carey LA, Lin W, Ewend MG. Blood vessel morphologic changes depicted with MR angiography during treatment of brain metastases: a feasibility study. Radiology. 2007 Dec; 245(3):824-30. PMID: 17954616; PMCID: PMC2615672.
  196. Parks GK, Lee E, Lin N, Mozer F, Wilber M, Dandouras I, Rème H, Lucek E, Fazakerley A, Goldstein M, Gurgiolo C, Canu P, Cornilleau-Wehrlin N, Décréau P. Solitary electromagnetic pulses detected with super-Alfvénic flows in Earth's geomagnetic tail. Phys Rev Lett. 2007 Jun 29; 98(26):265001. PMID: 17678094.
    View in: PubMed
  197. Lin NU, Dieras V, Paul D, Lossignol D, Christodoulou C, Laessig D, Roche H, Zembryki D, Oliva CR, Winer EP. EGF 105084, a phase II study of lapatinib for brain metastases in patients (pts) with HER2+ breast cancer following trastuzumab (T) based systemic therapy and cranial radiotherapy (RT). J Clin Oncol. 2007; 25(18S):abstract 1012.
  198. Lin NU, Winer EP. Optimal use of aromatase inhibitors: to lead or to follow? J Clin Oncol. 2007 Jul 01; 25(19):2639-41. PMID: 17563391.
    View in: PubMed
  199. Lin NU, Winer EP. Brain metastases: the HER2 paradigm. Clin Cancer Res. 2007 Mar 15; 13(6):1648-55. PMID: 17363517.
    View in: PubMed
  200. Lin NU, Parker LM, Come SE, Burstein HJ, Haldoupis M, Ryabin N, Gelman R, Winer EP, Shulman LN. Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactions. Invest New Drugs. 2007 Aug; 25(4):369-75. PMID: 17345004.
    View in: PubMed
  201. Mayer EL, Lin NU, Burstein HJ. Novel approaches to advanced breast cancer: bevacizumab and lapatinib. J Natl Compr Canc Netw. 2007 Mar; 5(3):314-23. PMID: 17439759.
    View in: PubMed
  202. Lin NU, Winer EP. Anatomy versus biology: to what extent should estrogen receptor (ER) status influence the decision to recommend adjuvant chemotherapy?. Breast Dis Quart. 2007; 18(3):232-4.
  203. Tolaney SM, Lin NU, Winer EP. HER2-positive breast cancer. J Clin Outcomes Management. 2007; 14(7):395-403.
  204. Lin NU, Carey LA, Liu MC, Younger J, Come SE, Bullitt E, Van Den Abbeele AD, Li X, Hochberg FH, Winer EP. Phase II trial of lapatinib for brain metastases in patients with HER2+ breast cancer. J Clin Oncol. 2006 Jun 20; 24(18_suppl):503. PMID: 27953633.
    View in: PubMed
  205. Kilpatrick MR, Lin NU, Smith JK, Winer EP, Bullitt E, Carey LA, Ewend MG. Superiority of bi-dimensional measurements compared to RECIST in measuring response of metastatic brain tumors. J Clin Oncol. 2006; 24(18S):68s.
  206. Harris LN, Broadwater G, Lin NU, Miron A, Schnitt SJ, Cowan D, Lara J, Bleiweiss I, Berry D, Ellis M, Hayes DF, Winer EP, Dressler L. Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342. Breast Cancer Res. 2006; 8(6):R66. PMID: 17129383; PMCID: PMC1797029.
  207. Bullitt E, Lin NU, Ewend MG, Zeng D, Winer EP, Carey LA, Smith JK. Tumor therapeutic response and vessel tortuosity: preliminary report in metastatic breast cancer. Med Image Comput Comput Assist Interv. 2006; 9(Pt 2):561-8. PMID: 17354817; PMCID: PMC2504703.
  208. Van den Abbeele AD, Lin NU, Yap JT, Urban T, deVries DJ, Barnes AS, Carey LA, Liu MC, Winer EP. Evaluation of response to lapatinib in patients with HER2-positive metastatic breast cancer using FDG-PET. Breast Ca Res Treat. 2006; 100(Suppl 1):S67.
  209. Zou W, Yue P, Lin N, He M, Zhou Z, Lonial S, Khuri FR, Wang B, Sun SY. Vitamin C inactivates the proteasome inhibitor PS-341 in human cancer cells. Clin Cancer Res. 2006 Jan 01; 12(1):273-80. PMID: 16397052.
    View in: PubMed
  210. Lin NU, Gelman R, Winer EP. Dose density in breast cancer: a simple message? J Natl Cancer Inst. 2005 Dec 07; 97(23):1712-4. PMID: 16333021.
    View in: PubMed
  211. Yang J, Li W, Duan M, Zhou Z, Lin N, Wang Z, Sun J, Xu J. Large dose ketamine inhibits lipopolysaccharide-induced acute lung injury in rats. Inflamm Res. 2005 Mar; 54(3):133-7. PMID: 15883747.
    View in: PubMed
  212. Lin N, Winer EP. Adjuvant breast cancer treatment: evolution or revolution?. Breast International Group (BIG) Newsletter. 2005; 7(2):1-4.
  213. Winer EP, Lin NU. HER2 inhibition in the adjuvant breast cancer setting. Am J Oncol Rev. 2005; 4(10):17-20.
  214. Lin NU, Bellon JR, Winer EP. CNS metastases in breast cancer. J Clin Oncol. 2004 Sep 01; 22(17):3608-17. PMID: 15337811.
    View in: PubMed
  215. Lin NU, Winer EP. New targets for therapy in breast cancer: small molecule tyrosine kinase inhibitors. Breast Cancer Res. 2004; 6(5):204-10. PMID: 15318926; PMCID: PMC549180.
  216. Lin NU, Broadwater G, Dressler LG, Schnitt S, Lara J, Bleiweiss I, Ngo T, Miron A, Winer E, Harris LN. The predictive value of HER2 and p53 on outcomes after paclitaxel chemotherapy for metastatic breast cancer: Results from CALGB 9342. J Clin Oncol. 2004 Jul 15; 22(14_suppl):9562. PMID: 28016843.
    View in: PubMed
  217. Lin NU, Sarantopoulos S, Stone JR, Galinsky I, Stone RM, Deangelo DJ, Soiffer RJ. Fatal hepatic necrosis following imatinib mesylate therapy. Blood. 2003 Nov 01; 102(9):3455-6. PMID: 14568907.
    View in: PubMed
  218. Lin N, Brakora K, Seiden M. BMS-247550 Bristol-Myers Squibb/GBF. Curr Opin Investig Drugs. 2003 Jun; 4(6):746-56. PMID: 12901236.
    View in: PubMed
  219. Lin N, Brakora K, Seiden M. BMS-247550. Current Opin Investigational Drugs. 2003; 4:746-56.
  220. Nichols G, de Castro K, Wei LX, Griffin M, Lin N, Oratzi A, Murty VV, Troxel A, Vahdat L, Hesdorffer C. Therapy-related myelodysplastic syndrome after autologous stem cell transplantation for breast cancer. Leukemia. 2002 Sep; 16(9):1673-9. PMID: 12200680.
    View in: PubMed
  221. Sabath DF, Lofton-Day C, Lin N, Lok S, Kaushansky K, Broudy VC. Identification and characterization of an isoform of murine Mpl. Biochim Biophys Acta. 2002 Apr 12; 1574(3):383-6. PMID: 11997107.
    View in: PubMed
  222. Cannone JJ, Subramanian S, Schnare MN, Collett JR, D'Souza LM, Du Y, Feng B, Lin N, Madabusi LV, Müller KM, Pande N, Shang Z, Yu N, Gutell RR. The comparative RNA web (CRW) site: an online database of comparative sequence and structure information for ribosomal, intron, and other RNAs. BMC Bioinformatics. 2002; 3:2. PMID: 11869452; PMCID: PMC65690.
  223. Cao X, Zhang W, Gao Y, Zhao X, Lin N, Wang L, Li C, Song L, Zhang W, Zhang Z, van Kets H, Wildemeersch D. Immediate post-abortal insertion of the frameless GyneFix IUD: initial experience in China. Br J Fam Plann. 2000 Apr; 26(2):85-8. PMID: 10773600.
    View in: PubMed
  224. Papadopoulos KP, Murty VV, Lin N, Matsushima A, Riemer E, Rao PH, Nichols GL. Translocation (4;15)(p16;q24): a novel reciprocal translocation in a patient with BCR/ABL negative myeloproliferative syndrome progressing to blastic phase. Cancer Genet Cytogenet. 1999 May; 111(1):18-20. PMID: 10326585.
    View in: PubMed
  225. Tsuang MT, Lyons MJ, Meyer JM, Doyle T, Eisen SA, Goldberg J, True W, Lin N, Toomey R, Eaves L. Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry. 1998 Nov; 55(11):967-72. PMID: 9819064.
    View in: PubMed
  226. Neuman E, Ladha MH, Lin N, Upton TM, Miller SJ, DiRenzo J, Pestell RG, Hinds PW, Dowdy SF, Brown M, Ewen ME. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol Cell Biol. 1997 Sep; 17(9):5338-47. PMID: 9271411; PMCID: PMC232384.
  227. McClure L, Eccleshall TR, Gross C, Villa ML, Lin N, Ramaswamy V, Kohlmeier L, Kelsey JL, Marcus R, Feldman D. Vitamin D receptor polymorphisms, bone mineral density, and bone metabolism in postmenopausal Mexican-American women. J Bone Miner Res. 1997 Feb; 12(2):234-40. PMID: 9041055.
    View in: PubMed
  228. Tsuang MT, Lyons MJ, Eisen SA, Goldberg J, True W, Lin N, Meyer JM, Toomey R, Faraone SV, Eaves L. Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs. Am J Med Genet. 1996 Sep 20; 67(5):473-7. PMID: 8886164.
    View in: PubMed
  229. Lin NU, Malloy PJ, Sakati N, al-Ashwal A, Feldman D. A novel mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor causes hereditary 1,25-dihydroxyvitamin D-resistant rickets. J Clin Endocrinol Metab. 1996 Jul; 81(7):2564-9. PMID: 8675579.
    View in: PubMed
  230. Lin N, Lai G. Urban stress in China. Soc Sci Med. 1995 Oct; 41(8):1131-45. PMID: 8578336.
    View in: PubMed
  231. Moulton T, Crenshaw T, Hao Y, Moosikasuwan J, Lin N, Dembitzer F, Hensle T, Weiss L, McMorrow L, Loew T, et al. Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nat Genet. 1994 Jul; 7(3):440-7. PMID: 7920666.
    View in: PubMed
  232. Broudy VC, Morgan DA, Lin N, Zsebo KM, Jacobsen FW, Papayannopoulou T. Stem cell factor influences the proliferation and erythroid differentiation of the MB-02 human erythroleukemia cell line by binding to a high-affinity c-kit receptor. Blood. 1993 Jul 15; 82(2):436-44. PMID: 7687159.
    View in: PubMed
  233. Xu Y, Wang Y, Zhang ZT, Lin N, Qian SZ. [Intratesticular subcapsular assay, a simple method for the preliminary screening of male contraceptives]. Yao Xue Xue Bao. 1993; 28(9):647-50. PMID: 8010008.
    View in: PubMed
  234. Adamson JW, Singer JW, Catalano P, Murphy S, Lin N, Steinmann L, Ernst C, Fialkow PJ. Polycythemia vera. Further in vitro studies of hematopoietic regulation. J Clin Invest. 1980 Dec; 66(6):1363-8. PMID: 7440720; PMCID: PMC371622.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Lin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_